FDA approves Recor Medical’s Paradise Ultrasound RDN System for hypertension treatment
The U.S. Food and Drug Administration (FDA) has granted approval to Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd., for the Paradise Ultrasound Renal Denervation (RDN) system. This groundbreaking technology presents a new adjunctive option for the treatment of patients whose hypertension is not adequately controlled by traditional means. A New […]